http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H10511972-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7084 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30 |
| filingDate | 1996-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1998-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H10511972-A |
| titleOfInvention | Transdermal therapeutic system for the administration of (s) -3-methyl-5- (1-methyl-2-pyrrolidenyl) -isoxazole or one of its pharmaceutically acceptable salts |
| abstract | (57) [Summary]n(s) -3-methyl-5- (1-methyl-2-pyrrolidenyl) -isoxazole or a dosage form for the administration of one of its pharmaceutically acceptable salts, which is transdermal in the form of a patch A dosage form characterized as being present as a therapeutic system. |
| priorityDate | 1995-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.